Literature DB >> 2027112

In vivo protective effects of prophylactic treatment with tiaprofenic acid or intraarticular corticosteroids on osteoarthritic lesions in the experimental dog model.

J P Pelletier1, J Martel-Pelletier.   

Abstract

We examined the in vivo effects of prophylactic intraarticular corticosteroid injections and nonsteroidal antiinflammatory drugs (NSAID) (tiaprofenic acid) oral administration on cartilage lesions of osteoarthritis (OA) and osteophyte formation in 18 dogs in which the anterior cruciate ligament had been sectioned. Six of the dogs received no treatment; 5 had 3 injections of 5 mg triamcinolone hexacetonide at 0, 4 and 8 weeks postsurgery; and 7 were treated orally with 5 mg/kg/day tiaprofenic acid. The untreated dogs developed cartilage lesions on the tibial plateaus and femoral condyles with prominent osteophytes on both lateral and medial condyles. The number and size of the osteophytes were significantly reduced in the triamcinolone treated dogs (p less than 0.0001). Moreover, both triamcinolone and tiaprofenic acid treated groups showed a decrease in the grade and size of tibial plateau lesions, compared to the untreated dogs. There was a similar and statistically significant decrease in lesion size when the treated dogs (about 50 mm2) were compared to the untreated dogs (77 mm2). Histological studies revealed that both drugs also significantly decreased the severity of OA structural changes of the cartilage on both femoral condyles and tibial plateaus, although the response to triamcinolone was more pronounced. Our data confirm the effectiveness of prophylactic treatment with corticosteroids and tiaprofenic acid in preventing the progression of OA lesions in the dog model.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2027112

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  10 in total

1.  [Unusual digital articular destructions after radio-synovectomy and cortisone injection therapy for Bouchard arthrosis].

Authors:  K Jablonka; J Freyschmidt; C Uhlenbruck
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

Review 2.  Nonsteroidal anti-inflammatory drugs and chondroprotection. A review of the evidence.

Authors:  P Ghosh
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

Review 3.  Injection techniques and use in the treatment of sports injuries.

Authors:  W A Scott
Journal:  Sports Med       Date:  1996-12       Impact factor: 11.136

4.  Effects of the NSAIDs meloxicam and indomethacin on cartilage proteoglycan synthesis and joint responses to calcium pyrophosphate crystals in dogs.

Authors:  K D Rainsford; T M Skerry; P Chindemi; K Delaney
Journal:  Vet Res Commun       Date:  1999-03       Impact factor: 2.459

Review 5.  Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone.

Authors:  Arrigo F G Cicero; Giuseppe Derosa; Antonio Gaddi
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 6.  Tiaprofenic acid. A reappraisal of its pharmacological properties and use in the management of rheumatic diseases.

Authors:  G L Plosker; A J Wagstaff
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546

7.  The intra-articular administration of triamcinolone hexacetonide in the treatment of osteoarthritis. Its effects in a naturally occurring canine osteoarthritis model.

Authors:  João C Alves; Ana Santos; Patrícia Jorge; Catarina Lavrador; L Miguel Carreira
Journal:  PLoS One       Date:  2021-01-20       Impact factor: 3.752

8.  Intra-Articular Slow-Release Triamcinolone Acetonide from Polyesteramide Microspheres as a Treatment for Osteoarthritis.

Authors:  Anna Tellegen; Martijn Beukers; Imke Rudnik-Jansen; Nicolien van Klaveren; Kan Loi How; Nina Woike; George Mihov; Jens Thies; Erik Teske; Laura Creemers; Marianna Tryfonidou; Björn Meij
Journal:  Pharmaceutics       Date:  2021-03-11       Impact factor: 6.321

Review 9.  Activity and potential role of licofelone in the management of osteoarthritis.

Authors:  Arrigo F G Cicero; Luca Laghi
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

10.  Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities.

Authors:  Yves Henrotin; Xavier Chevalier; Gabriel Herrero-Beaumont; Timothy McAlindon; Ali Mobasheri; Karel Pavelka; Christiane Schön; Harrie Weinans; Hans Biesalski
Journal:  BMC Res Notes       Date:  2013-03-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.